Kanabo Group (LSE:KNB), a health-tech company focused on patient care with its innovative digital healthcare platform and medical cannabis treatment portfolio, announced Ian Mattioli's appointment as chair of the board.

The £2.5 million ($3.15 million) minimum investment round includes an institutional investor, company management, and Ian Mattioli's £500,000 investment. This funding will support Kanabo's UK market expansion, further developing its telehealth offering, and accelerating the integration of additional treatments into its digital health platform and medical cannabis product line.

David Tsur, Kanabo's outgoing chair, welcomed Mattioli to the leadership team, stating:

"We are pleased to …

Full story available on Benzinga.com

A note to our visitors

This website has updated its privacy policy in compliance with changes to European Union data protection law, for all members globally. We’ve also updated our Privacy Policy to give you more information about your rights and responsibilities with respect to your privacy and personal information. Please read this to review the updates about which cookies we use and what information we collect on our site. By continuing to use this site, you are agreeing to our updated privacy policy.